The increasing demand for performance has stimulated the wide adoption of many-core accelerators like Intel R Xeon Phi TM Coprocessor, which is based on Intel's Many Integrated Core architecture. While many HPC applications running in native mode have been tuned to run efficiently on Xeon Phi, it is still unclear how a managed runtime like JVM performs on such an architecture. In this paper, we present the first measurement study of a set of Java HPC applications on Xeon Phi under JVM. One key obstacle to the study is that there is currently little support of Java for Xeon Phi. This paper presents the result based on the first porting of OpenJDK platform to Xeon Phi, in which the HotSpot virtual machine acts as the kernel execution engine. The main difficulty includes the incompatibility between Xeon Phi ISA and the assembly library of Hotspot VM. By evaluating the multithreaded Java Grande benchmark suite and our ported Java Phoenix benchmarks, we quantitatively study the performance and scalability issues of JVM on Xeon Phi and draw several conclusions from the study. To fully utilize the vector computing capability and hide the significant memory access latency on the coprocessor, we present a semi-automatic vectorization scheme and software prefetching model in HotSpot. Together with 60 physical cores and tuning, our optimized JVM achieves averagely 2.7x and 3.5x speedup compared to Xeon CPU processor by using vectorization and prefetching accordingly. Our study also indicates that it is viable and potentially performance-beneficial to run applications written for such a managed runtime like JVM on Xeon Phi.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.